Price of the Indian version of the targeted drug Erdafitinib

Erdafitinib (Erdafitinib) is a targeted drug for the treatment of bladder cancer. It is understood that there are currently no Indian versions of the original Erdafitinib drug or generic drugs on the market. Erdafitinib is marketed to treat urothelial cancer (bladder cancer) that has spread or cannot be removed with surgery. It is used in patients whose cancer has an abnormal "FGFR" gene, and in patients who have tried at least one other platinum-containing chemotherapy drug without success. Common manufacturers of erdafitinib generic drugs include Bangladesh Yaopin International, Laos ASEAN Pharmaceuticals, etc. The price of each box of 4mg*60 tablets may be more than 3,000 yuan (the price may fluctuate due to the exchange rate), and its drug ingredients are basically the same as those of the original drug.